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Abstract
Introduction: The Calypso 4D Localization System gives the possibility to track the tumour during treatment,
with no additional ionising radiation delivered. To monitor the patient continuously an array is positioned
above the patient during the treatment. We intend to study, for various gantry angles, the attenuation effect
of the array for 6- and 10 MV and ﬂattening ﬁlter free (FFF) 6- and FFF 10 MV photon beams.
Materials and methods: Measurements were performed using an ion chamber placed in a slab phantom
positioned at the linac isocenter for 6 MV, 10 MV, FFF 6 MV and FFF 10 MV photon beams. Measurements were
performed with and without array above the phantom for 0°, 10°, 20°, 40° and 50° beam angle for a
True Beam STx linac, for 5× 5 and 10× 10 and 15× 15 cm2 ﬁeld size beams to evaluate the attenuation of the
array. A VMAT treatment plan was measured using an ArcCheck with and without the array in the beam path.
Results and discussion: Attenuation measured values were up to 3%. Attenuation values were between 1 and
2% with the exception of the 30°–50° gantry angles which were up to 3.3%. The ratio values calculated in
the ArcCheck for relative dose and absolute dose 10 were both 1·00.
Conclusion: Attenuation of the treatment beam by the Calypso array is within acceptable limits.
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INTRODUCTION
Higher accuracy and reproducibility in radio-
therapy has led to great development in imaging
and monitoring systems. Megavoltage imaging
has been used clinically for many years, and kV
imagers have also been installed in linacs all over
the world. Monitoring systems for tracking
movement during treatment have been used to
monitor patient surface – for example infrared
tracking of external markers or virtual view of the
patient surface – or the tumour movement – for
example ﬂuoroscopy.1–11
The Calypso 4D Localization System (Varian
Medical Systems, Palo Alto, CA, USA) is a
monitoring system that gives the possibility to
track the tumour during treatment, with no
additional ionising radiation delivered, a great
advantage when compared with other systems
available.12
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This system has ﬁve components: Beacon
transponders, the console, the array, the optical
localisation subsystem and the monitoring station.
The array consists of optical targets, 4 sources and
32 receiver coils.13 An oscillating signal (25Hz)
through the source coil generates resonance in the
transponders. When this signal is turned off, the
transponders emit electromagnetic signals, which
are detected by the receiver coils in the array,
thereby localising their positions relative to the
array. Meanwhile, the in-room infrared camera
system tracks the array relative to the isocenter.14
To monitor the patient continuously an array
is used. This array is positioned above the patient
during the treatment.13,15
Although the array lies between the patient
and the beam, it is not included in the dose cal-
culation of the treatment planning system.
Zou et al. studied the array attenuation effect for
the regular energies 6 and 15MV photon beams for
various gantry angles – and concluded that the dose
difference due to the placement of Calypso array
was clinically insigniﬁcant to the treatment.16 In our
institute the Calypso system is mainly used in the
irradiation of ﬂattening ﬁlter free (FFF) beams.
Given that the removal of the ﬂattening ﬁlter lowers
the mean energy of the beam we propose to study,
for various gantry angles, the attenuation effect of
the array for FFF 6 and FFF 10MV photon beams.
It is also to be noticed that pointmeasurements of an
inhomogeneous arraymay lead to uncertainties, as it
contains source coils, sensors and infrared targets.
Considering that the Calypso system has been used
mainly in prostate treatments, a QA of a prostate
VMAT treatment plan was performed with and
without the Calypso array in the beam.
MATERIALS AND METHODS
All transmission measurements were performed on
aTrue Beam STx linear accelerator (VarianMedical
Systems) using a CC13 ionisation chamber of
0·13 cm3 of sensitive volume (IBA Dosimetry,
Germany) connected to a Dose 1 electrometer
(IBA Dosimetry, Germany). Corrections for tem-
perature and pressure were applied.
Attenuation effect of the array for 6- and
10MV and FFF 6- and FFF 10MV photon
beams
The ionisation chamber was inserted in a slab
phantom and positioned in the isocenter at 5 cm
depth. The array was positioned above the phan-
tom in the (0, 0, 0) position indicated by Calypso
software system, in the same way it is positioned
above the patient during treatment (see Figure 1).
Figure 1. Gantry angle measurements acquisition scheme.
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Measurements were performed for regular 6-
and 10MV and FFF 6- and FFF 10MV energies,
for 5 × 5 and 10× 10 and 15× 15 cm2 square
ﬁeld sizes. The readings were obtained in six
different gantry angles: 0°, 10°, 20°, 30°, 40° and
50°. Further gantry angles were not considered in
this study as the centre of the beam would not
traverse the array. For each measurement, 200
monitor units (MU) were delivered at a dose rate
of 600MU/minute for regular beam energies
and 800MU/minute for FFF energies.
Measures were performedwith andwithout the
array in the beam path. Each measurement was
repeated ﬁve times. The transmission measure-
ments were registered in a table. The attenuation
was calculated according to the formula:
Attenuationð% Þ
¼ 1 - Measurement with array
Measurement without array
 
´ 100
The attenuation calculated values were regis-
tered and analysed. Mean and standard deviation
were calculated.
A ﬁt was done to the attenuation curves to
evaluate the goodness of the ﬁt.
Attenuation effect of the array for a FFF
10MV prostate treatment
An ArcCheck system (SunNuclear, Melbourne,
FL, USA) was used to measure the dose delivered
and to compare with the expected dose.
A computed tomography of the ArcCheck
was imported in our Treatment Planning
System (TPS) Eclipse (Varian Medical Systems).
A prostate patient previously treated was selected
randomly. The treatment consisted of a VMAT
plan for a 28× 2·25 Gy irradiation of prostate and
seminal vesicles. This plan was recalculated in the
ArcCheck CT.
The ArcCheck was positioned in the isocenter,
and the array was positioned above the phantom in
the (0, 0, 0) position indicated by Calypso software
system, as performed during patient treatment.
Repeated ArcCheck measurements of the
patient treatment were performed with and
without the array in the beam path. A standard
deviation was calculated for both conditions.
All measured maps were compared to the dose
map calculated. Comparison was evaluated for
3% dose for 3 mm for relative dose (RD) and
absolute dose (AD) for all measured points except
those with 10% dose or less, according to the
local protocol.
Figure 2. Attenuation by Calypso array of 5× 5 cm2 ﬁeld
size beams.
Figure 3. Attenuation by Calypso array of 10× 10 cm2 ﬁeld
size beams.
Figure 4. Attenuation by Calypso array of 15× 15 cm2 ﬁeld
size beams.
Calypso’s array attenuation
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The ratio percentage dose (between measures
with and without the array) was calculated and
analysed.
RESULTS AND DISCUSSION
Attenuation effect of the array for 6- and
10MV and FFF 6- and FFF 10MV photon
beams
The attenuation values measured were higher
for 5 × 5 cm2 ﬁelds than for 10 × 10 cm2 ﬁelds
for all energies and for the same measurement
conditions. Also, the attenuation values mea-
sured were higher for 10 × 10 cm2 ﬁelds than for
15 × 15 cm2 ﬁelds for all energies and for the
same measurement conditions. Therefore, the
data shows that the beam attenuation is ﬁeld size
dependent. This dependency was not calculated.
Field size dependency has been previously
reported in other devices attenuation studies,
although this dependency was also not quantiﬁ-
able in those reports.17–19
These studies usually also report an angular
dependence on the attenuation of the beam
by devices. A second degree polynomial ﬁt was
applied to the attenuation curves. For the
5× 5 cm2 ﬁeld size curves, the r2 value for 6MV,
10MV, FFF 6MV and FFF 10MV of 0·98; 0·97;
0·97 and 0·97, respectively. For 10× 10 cm2 ﬁeld
size curves, the r2 value was 0·96; 0·98; 0·98 and
0·99, for the same energies, respectively. For
15× 15 cm2 ﬁeld size curves, the r2 value was
0·97; 0·96; 0·98 and 0·96, for the same energies,
respectively. Therefore, there is a tendency for
higher attenuation values as the gantry angle
increases, as it is shown in Figures 2, 3 and 4.
All points measured showed 0·0 or 0·1% stan-
dard deviation. Measurements can be considered
precise.
The array attenuation calculated values are
comparable to attenuation values presented pre-
viously. Zou et al. reported that the attenuation
on the array was about 2–3% for both 6 and
15MV energies, for 1 × 1 cm2 ﬁeld size beams at
gantry angles between 0° and 40°. The calculated
attenuation slowly increased above these values
for angles around 50°–60°.16
Here the calculated attenuation values were
between 1% and 2% for gantry angles 0°, 10° and
20°, for both ﬁeld sizes for all energy beams.
Acquisitions at 30°, 40° and 50° gantry angles
Figure 5. Portal image of Calypso’s array.
Calypso’s array attenuation
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showed higher attenuation values. The higher
attenuation calculated value was 3·4% for a
5 × 5 cm2 ﬁeld for a FFF 6MV beam (gantry
angle: 50°), and 3·3% for a 10× 10 cm2 ﬁeld and
3·1% for a 15× 15 cm2, both for the same energy
beam, at the same gantry angle.
Array attenuation values can be considered
acceptable. Nevertheless it is to be noticed
that point measurements were performed and
because the FFF energy beams are not ﬂat by
deﬁnition, positioning accuracy of the ionisation
chamber can be challenging. Furthermore, the
array is also inhomogeneous, as it contains source
coils, sensors and infrared targets as it is shown
in Figure 5. A 2D Electronic Portal Imaging
Device detector could be used to assess that,
however it has to be compatible with the use of
FFF beams.
Attenuation effect of the array for a FFF
10MV prostate treatment
The repeated measurements without array above
the ArcCheck showed less than 0·4% standard
deviation for both RD and AD10 evaluations.
The repeated measurements with the array above
the ArcCheck showed less than 0·5% standard
deviation for the same evaluations.
The ratio values calculated for RD were all
1·00. For the AD there was one ratio value of
1·01. The mean values for the two evaluation
methods were all 1·00. Therefore the presence of
the array in the beam path is negligible.
CONCLUSION
The behaviour of the array attenuation curves is
important to study due to its inhomogeneous
structure.
Dose attenuations were measured to be within
1–2% with the exception of the 30°–50° gantry
angles which were up to 3·4%. The results indi-
cate that the dose attenuation of the Calypso
array may be within acceptable limits.
Future work should assess the Calypso attenua-
tion of radiotherapy treatment beams with more
detail.
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